EORTC-20021-LYMG

Gem-(R)CHOP versus (R)CHOP : a randomized Phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's Lymphoma
Study documentation
Trial StatusAll trial activities ended
DatesDate of activation: 26-Jan-04
Closed on : 23-Mar-07
Data management at EORTCFull
Phase2
Randomized trialYes
TypeHemato-malign
Targeted Sample size84
Number of steps1
Drug
Study Staff
Type of cancerNon Hodgkins Lymphoma
Participating GroupsEORTC Lymphoma Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT numberNCT00079261
EudraCT